US Broker Ratings

Valneva SE (VALN) Stock Analysis: A 51.89% Upside Potential in the Biotechnology Sector

Valneva SE (NASDAQ: VALN), a French biotechnology company specializing in vaccines for infectious diseases, presents a compelling opportunity for investors seeking exposure to the healthcare sector...

Altimmune, Inc. (ALT) Stock Analysis: Exploring a Potential 345.98% Upside in the Biotech Sector

Investors with a keen eye on the biotechnology sector might find Altimmune, Inc. (NASDAQ: ALT) a compelling prospect, given its significant potential upside of 345.98%. This..

Auna SA (AUNA) Stock Analysis: Exploring a 124% Potential Upside for Healthcare Investors

Auna SA (AUNA), a key player in the healthcare sector, is capturing attention with its remarkable potential upside of 124.01%, derived from analyst target prices. Based..

Maze Therapeutics, Inc. (MAZE) Stock Analysis: Strong Buy Ratings Propel 10.64% Upside Potential

Maze Therapeutics, Inc. (NASDAQ: MAZE) is capturing the attention of investors with its robust pipeline and promising clinical-stage developments in the biotechnology sector. Based in South..

PureTech Health plc (PRTC) Stock Analysis: A Biotech Powerhouse with 542% Revenue Growth

PureTech Health plc (NASDAQ: PRTC), a U.S.-based biotechnology firm, has been attracting attention with its staggering 542.70% revenue growth. Despite its relatively modest market capitalization of..

Tourmaline Bio, Inc. (TRML) Investor Outlook: Biotech’s Promising Pipeline Amidst Technical Strengths

Tourmaline Bio, Inc. (NASDAQ: TRML) is making waves in the biotechnology industry with its innovative approach to tackling immune and inflammatory diseases. Headquartered in New York,..

Savara, Inc. (SVRA) Stock Analysis: A Biotech Contender with a 68.95% Potential Upside

Savara, Inc. (NASDAQ: SVRA), a clinical-stage biopharmaceutical firm, is making waves in the biotechnology sector with its promising focus on rare respiratory diseases. Headquartered in Langhorne,..

Autolus Therapeutics plc (AUTL): Investor Outlook with a 466.80% Potential Upside

Autolus Therapeutics plc (NASDAQ: AUTL) presents a compelling opportunity for investors looking to delve into the biotechnology sector, with a potential upside of 466.80% according to..

Avanos Medical, Inc. (AVNS) Stock Analysis: Navigating Challenges with Strategic Innovations in Medical Devices

Avanos Medical, Inc. (NYSE: AVNS) operates at the intersection of healthcare innovation and medical technology—a critical juncture for investors seeking to engage with the medical devices..

Owens & Minor, Inc. (OMI) Stock Analysis: Exploring a 110% Potential Upside Amidst Market Challenges

Owens & Minor, Inc. (NYSE: OMI), a pivotal player in the healthcare sector, is currently navigating through a complex market landscape. The company’s stock, trading at..

EyePoint, Inc. (EYPT) Stock Analysis: A Potential 97% Upside with an Eye on Biotech Innovations

EyePoint, Inc. (NASDAQ: EYPT) stands as a compelling opportunity in the biotechnology sector, promising significant potential upside for astute investors. With a market capitalization of $1.51..

SIGA Technologies Inc. (SIGA): Investor Outlook with Strong Forward P/E as a Highlight

SIGA Technologies Inc. (NASDAQ: SIGA) stands out in the healthcare sector as a commercial-stage pharmaceutical company with a targeted focus on the health security market. Headquartered..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating the Volatility with a 19.72% Upside Potential

For investors keeping a close eye on the biotechnology sector, Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) presents an intriguing mix of innovation and volatility. As a..

Orthofix Medical Inc. (OFIX) Investor Outlook: Analyzing the 50.40% Potential Upside

Orthofix Medical Inc. (NASDAQ: OFIX) stands at a fascinating crossroads for investors, blending its robust presence in the healthcare sector with a strategic focus on medical..

Precigen, Inc. (PGEN) Stock Analysis: A Biotech Play with Over 100% Upside Potential

Precigen, Inc. (NASDAQ: PGEN) is making waves in the biotechnology sector with its innovative gene and cell therapy platforms. Based in Germantown, Maryland, this clinical-stage biopharmaceutical..

Replimune Group, Inc. (REPL) Investor Outlook: Navigating Biotech Potential with a 24.59% Upside

Replimune Group, Inc. (NASDAQ: REPL) is garnering attention in the biotechnology sector with its promising oncolytic immunotherapy product candidates aimed at treating cancer. This clinical-stage company,..

Talkspace, Inc. (TALK) Investor Outlook: Analysts Predict a 33% Upside for This Healthcare Innovator

In the rapidly evolving healthcare sector, Talkspace, Inc. (NASDAQ: TALK) stands out as a forward-thinking player in the field of mental health services. With a market..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Navigating Volatility with a 20.48% Potential Upside

Cross Country Healthcare, Inc. (NASDAQ: CCRN) offers a comprehensive range of talent management services for healthcare clients across the United States. With a market capitalization of..

Zevra Therapeutics, Inc. (ZVRA)

⚠️ No article content returned.

..

LifeMD, Inc. (LFMD) Stock Analysis: Exploring a 131% Potential Upside

LifeMD, Inc. (NASDAQ: LFMD), a dynamic player in the healthcare sector, is capturing the attention of investors with its robust telehealth services and significant growth potential...

US Broker Ratings

US Broker Ratings

FTSE 100

Funds